ABIVAX publishes its number of shares and voting rights as of February 29, 2024

On March 27, 2024, ABIVAX, a company listed on Euronext Paris (FR0012333284 – ABVX), communicated essential information regarding its share capital and voting rights. Based in Paris, the company announced that, as of February 29, 2024, the capital consisted of 62,928,818 shares. The total number of theoretical voting rights amounted to 69,930,243, taking into account non-voting shares.

The exercisable voting rights, therefore excluding shares deprived of voting rights, were 69,919,087. This distinction between theoretical and exercisable voting rights provides necessary transparency to investors, in accordance with the AMF recommendations issued on July 17, 2007. .

This update is part of the French regulatory framework, aiming to provide clear and predictable information on the capital structure and voting rights to the company's stakeholders.